Immunowake
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech developing immunotherapies and vaccines for infectious diseases and cancer.
Infectious DiseaseOncologyVaccines
Technology Platform
Focuses on novel antigen design and delivery systems to develop vaccines and immunotherapies that elicit targeted immune responses.
Opportunities
Potential to address specific, high-prevalence infectious diseases or cancers in the Chinese market with tailored immunotherapies.
Risk Factors
High risk of clinical failure common to early-stage biotechs and dependence on successful fundraising to advance its pipeline.
Competitive Landscape
Operates in the crowded and capital-intensive global vaccine and immuno-oncology sectors, competing with giants like Sinovac and Innovent, as well as numerous startups.